Skip to main content
Home

Breadcrumb

  1. Home
  2. Healthcare and Life Science

Healthcare and Life Science

2 November 2022

The Native Antigen Company expands its range of Omicron antigens to include BA.5 variant

New antigens support research into BA.5 variant, currently responsible for over half of global COVID-19 cases. ...

1 November 2022

Close your open roles in 2022 with Biotech Search in 6-8 weeks

You've got time to secure talent before the holidays if you start now. We regularly work with UK Biotechs who need to supercharge their recruitment ... we guarantee our results with a 6-month free placement on your new hire. ...

1 November 2022

Ellutia showcasing fully automated total nitrosamine testing system at Lab Innovations 2022

At Lab Innovations 2022, Ellutia will present the newest addition to its nitrosamine detection solutions, the Automated Total Nitrosamine Analyser (ATNA). The fully automated solution allows for rapid testing of apparent total nitrosamine content (ATNC) and has the right selectivity and...

31 October 2022

Ubiquigent obtains exclusive license for UbiSite technology to strengthen its specialist drug discovery services

Dundee, UK - Ubiquigent Limited (Ubiquigent), a drug discovery and development company harnessing novel deubiquitylase (DUB) modulators as new therapeutics for areas of high unmet medical need, has signed an exclusive license with the University of Southern Denmark for its UbiSite®...

31 October 2022

Innovate UK EDGE prepares biotech client Bilitech for Investment

Bilitech Ltd a SME based in Cambridge has developed a technology to manufacture bioengineered bile ducts in the laboratory and aims to translate it to the clinic for use in patients. Bilitech specialises in the treatment of biliary disease, focusing on the use of bioengineered bile duct...

28 October 2022

Nuclera Nucleics Ltd grows and scale with support from Innovate UK EDGE support

With support from Innovate UK EDGE, biotech company Nuclera Nucleics were able to create a commercialisation plan, secured Series B funding and are on track to double their headcount by the end of 2022. ...

28 October 2022

Wear it Pink!

Last week Corazon Health took part in 'Wear It Pink' event to raise much needed funds for Breast Cancer Now to help make life-saving breast cancer research and vital support happen. ...

26 October 2022

Cresset's October 2022 Newsletter

Read about Cresset's latest case studies, published papers, and upcoming events

26 October 2022

Cambridge Filmworks produce a suite of new films for Genomics England

Genomics England mission is to turn science into healthcare, using technology – for everyone. They handle the huge quantities of data produced by genomic sequencing in the NHS, to improve patient treatment and empower research into new therapeutic discoveries. The Genomics England team ...

25 October 2022

Sphere Fluidics opens new laboratory facilities at Granta Park in Cambridgeshire, UK

Cambridge, UK - Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, announces that it has opened a new state-of-the-art facility in Granta Park, Cambridgeshire, UK, to support the Company’s growth. Doubling overall ...

Pagination

  • First page «
  • Previous page ‹‹
  • …
  • Page 231
  • Page 232
  • Current page 233
  • Page 234
  • Page 235
  • …
  • Next page ››
  • Last page »
Receive our newsletter

Cambridge Network Limited is a company registered in England under company No. 3400152

The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

Email: [email protected], Tel: 01223 746801

© 2026 Cambridge Network. All Rights Reserved.

Website by KISS